Actively Recruiting
Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
Led by Assistance Publique - Hôpitaux de Paris · Updated on 2022-02-23
6300
Participants Needed
1
Research Sites
520 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The primary objective: association study of characteristics of tumoral microenvironment and immunity of digestive cancers with patients' overall survival (OS).
CONDITIONS
Official Title
Interaction Between Host, Microenvironment and Immunity on Gastrointestinal Neoplasms
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosed with colorectal, pancreatic, biliary tract, gastro-oesophageal, or neuroendocrine digestive tumors confirmed by cytology or histology
- Diagnosis made between 1998 and 2030
- 18 years of age or older
- Provided signed informed consent (exemption for deceased patients)
- Affiliated with French social security or welfare system (including CMU)
You will not qualify if you...
- Under legal guardianship or curatorship
- Foreign patients under the AME medical help scheme in France
- Pregnant or breastfeeding women (for prospective study)
- Any clinical, psychological, or social condition affecting protocol compliance as judged by the investigator
- Patient refusal to participate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Digestive Surgery Department, Ambroise Paré Hospital, APHP
Boulogne-Billancourt, France, 92100
Actively Recruiting
Research Team
F
Frédérique PESCHAUD, MD, PhD
CONTACT
C
Cindy NEUZILLET, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
DIAGNOSTIC
Number of Arms
10
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here